Retrospective safety testing of the CT Clock method for identifying treatment-eligible patients with ischaemic stroke of unknown onset time: Study Protocol
Mair, G.; Chappell, F. M.
Show abstract
More than 100,000 people in the UK have an ischaemic stroke every year. This means a blood clot blocks an artery supplying blood to their brain. Patients with ischaemic stroke often have sudden weakness affecting half of their body or face, and problems with speech, although other stroke symptoms are possible. Treatment with a clot-busting drug (thrombolysis) can reduce the amount of disability and death caused by ischaemic stroke by restoring the blood supply to the brain. Thrombolysis usually needs to be given within four and a half hours of stroke occurring. Unfortunately, nearly three quarters of patients with ischaemic stroke arrive in hospital later than this, or it is not clear when their stroke started. For these patients, it may still be possible to treat them with thrombolysis if the hospital can provide an additional advanced type of brain scan. However, many hospitals in the UK and worldwide cannot offer this advanced scan to patients with stroke, particularly hospitals that are not in major cities or developed nations. Patients arriving at these hospitals therefore do not currently have the same access to effective treatment for stroke. We have developed a simple method for identifying which patients can be given thrombolysis even if they arrive at hospital later than four and a half hours, or where there is uncertainty about when their stroke started. Our method does not require any additional or advanced imaging, only the standard computed tomography (CT or CAT) scan that all patients with stroke get when they arrive at hospital. Our method is called the CT Clock. We ask doctors to look for stroke changes indicating ischaemic stroke in the brain on CT. If they find these stroke changes, they measure them compared to normal brain. If the stroke changes on CT are minor (less than 20% darker than normal brain), or the scan appears normal despite quite severe stroke symptoms, we would consider these patients suitable for treatment with thrombolysis. This study proposes to test the safety of our CT Clock method in an analysis of existing NHS data from patients who have previously been treated with thrombolysis. We aim to show that when doctors who provide stroke care use our CT Clock method to identify suitable patients for treatment with thrombolysis, it is safe for these patients. If successful, this study will allow us to plan for and deliver future clinical testing where we would use the CT Clock to identify patients for treatment with thrombolysis in hospitals where advanced imaging for stroke is unavailable. Successful clinical testing is needed before our method can be used routinely in hospitals around the world. Data Study Protocol O_TBL View this table: org.highwire.dtl.DTLVardef@18a7b6corg.highwire.dtl.DTLVardef@ad2388org.highwire.dtl.DTLVardef@f7ea61org.highwire.dtl.DTLVardef@3cc038org.highwire.dtl.DTLVardef@6faf1e_HPS_FORMAT_FIGEXP M_TBL C_TBL
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Effectiveness and Cost-Effectiveness of TeleStroke Consultations to Support the Care of Stroke Patients Presenting to Regional Emergency Departments in Western Australia: An Economic Evaluation Case Study Protocol 94%
- Measurement of quality of stroke care with national electronic health records: a cohort during and after the COVID-19 pandemic 92%
- Real-world effects of ACE inhibitors and Angiotensin Receptor Blockers: protocol for an emulation study of the ONTARGET trial using electronic health records 92%
Similar papers in this journal
- Intravenous Thrombolysis for Acute Central Retinal Artery Occlusion: Protocol For a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Controlled Trials 93%
- Non-invasive Auricular Vagus nerve stimulation for Subarachnoid Hemorrhage (NAVSaH): Protocol for a prospective, triple-blinded, randomized controlled trial 93%
- STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol 92%
Similar papers in this journal
- Effect of Time to Thrombolysis on Clinical Outcomes in Patients with Acute Ischemic Stroke Treated with Tenecteplase Compared to Alteplase: Analysis from the AcT Randomized Controlled Trial 93%
- Prospective Observational Cohort Study Of Tenecteplase Versus Alteplase In Routine Clinical Practice 93%
- Intracerebral Hemorrhage Outcomes after Reversal of Subtherapeutic Warfarin: Analysis of Data from GWTG-Stroke 93%
Similar papers in this journal
- Decision support system to evaluate VENTilation in the Acute Respiratory Distress Syndrome (DeVENT study) – Trial Protocol 93%
- Evaluating Diuretics in Normal Care (EVIDENCE): Protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension. 91%
- Statistical Analysis Plan for the Stepped-wedge Cluster Randomized Controlled Trial of Electronic Early Notification of Sepsis in Hospitalized Ward Patients (SCREEN): a study protocol for a stepped-wedge cluster randomized controlled trial 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.